Loading...
•
Dec 31, 2024
Health Catalyst Q4 2024 Earnings Report
Health Catalyst reported strong financial performance in the fourth quarter of 2024, with significant growth in total revenue and Adjusted EBITDA.
Key Takeaways
Health Catalyst achieved strong performance in Q4 2024, with total revenue reaching $79.6 million and Adjusted EBITDA at $7.9 million, significantly exceeding the previous year's figures. The Technology segment showed notable growth, contributing to the overall positive results.
Total revenue for Q4 2024 increased by 6% year-over-year to $79.6 million.
Adjusted EBITDA for Q4 2024 saw a substantial increase of 485% year-over-year, reaching $7.9 million.
The Technology segment's revenue for Q4 2024 was $51.6 million, contributing significantly to overall revenue.
Net loss for Q4 2024 improved to -$20.7 million from -$30.3 million in the prior year.
Revenue by Segment
Forward Guidance
Health Catalyst provided optimistic forward-looking guidance for Q1 and the full year 2025, anticipating continued revenue growth and increased Adjusted EBITDA.
Positive Outlook
- Anticipated total revenue for Q1 2025 of approximately $79 million.
- Anticipated Adjusted EBITDA for Q1 2025 of approximately $4 million.
- Anticipated total revenue for full year 2025 of approximately $335 million.
- Anticipated Technology revenue for full year 2025 of approximately $220 million.
- Anticipated Adjusted EBITDA for full year 2025 of approximately $41 million, an increase from previous targets.
Challenges Ahead
- Guidance for Adjusted EBITDA is not reconciled to net loss, the most directly comparable GAAP measure.
- Forward-looking guidance for net loss is not provided.
- Items impacting net loss, such as stock-based compensation, are not within control or reasonably forecasted.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...